Social Media Ideas for Cars International

Latest updates for Cars International

Fresh curated links around CARs International are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

kyrgyzstannews.net /1 month ago

Beyond Borders: ImmunoACT and India's Emergence as one of the World's Most Accessible CAR-T Destination

VMPLNew Delhi [India], April 29: A patient from Mauritius with relapsed aggressive non-Hodgkin's lymphoma travelled to India for an indigenously manufactured CAR-T cell therapy by...

Read source

labiotech.eu /4 weeks ago

Eight in vivo CAR T biotechs to follow closely

We have curated a list of in vivo CAR T biotechs in preclinical and clinical stages that you should keep an eye out for. The post Eight in vivo CAR T biotechs to follow closely ...

Read source

borgenproject.org /1 month ago

Reducing Maternal Deaths in CAR

The Central African Republic (CAR) has one of the highest maternal mortality rates in the world, at 835 deaths per 100,000 live births. A shortage of skilled health care providers...

Read source

qchron.com /1 month ago

Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer P...

SHANGHAI, May 31, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that...

Read source

qchron.com /1 month ago

From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma

SHANGHAI, May 24, 2026 /PRNewswire/ -- A 36-year-old Pakistani patient has achieved encouraging early recovery after receiving personalized CAR-T immunotherapy at Jiahui Internatio...

Read source

fiercebiotech.com /1 month ago

Caribou boosts case that off-the-shelf CAR-T matches autologous drugs ahead of phase 3

Caribou Biosciences has linked its CAR-T cell therapy candidate to 17.1-month median progression-free survival, adding to evidence that the off-the-shelf treatment can match the ef...

Read source

singularityhub.com /5 days ago

CAR T Revolutionized How We Treat Blood Cancers. Now It’s Closing In on Solid Tumors.

Separate teams discovered the same target in solid cancers, enabling a powerful two-pronged attack on both tumors and the cells shielding them. The post CAR T Revolutionized How We...

Read source

aacr.org /1 month ago

Bloodlines Series: CAR T-cell Therapy Shows Promise for Smoldering Myeloma

An immunotherapy typically used in advanced stages of multiple myeloma may be effective against an early form of the disease known as smoldering myeloma—offering a potential new op...

Read source

qchron.com /1 month ago

ASCO 2026 | Oricell's GPC3 CAR-T Ori-C101 Hits 66.7% ORR in Late-Line HCC, Signaling Best-in-Class Potential

CHICAGO, May 31, 2026 /PRNewswire/ -- Oricell Therapeutics, a clinical-stage biotech company pioneering cancer immunotherapy, today announced that its lead asset, Ori-C101, a GPC3-...

Read source

thisdaylive.com /1 month ago

Carloha Partners Okpekpe International Marathon

Bennett Oghifo Carloha Nigeria, the authorised dealer of Chery vehicles in Nigeria, has announced its participation as the Official Automobile Sponsor of the 11th edition of the O...

Read source

genengnews.com /2 weeks ago

Circio’s circVec and Tcelltech’s nanoSMAR Technologies Combined to Generate Nextgen In vivo CAR-T and TCR-T Cells

Circio and Tcelltech will combine Circio's circVec circular RNA expression technology with Tcelltech's non-viral, high-cargo capacity nanoSMAR vector platform and evaluate the comb...

Read source

fiercebiotech.com /2 weeks ago

China approved the world’s first solid tumor CAR-T therapy. When will the US follow?

CAR-T cell therapy has flourished since it was first used in 2010, leading to eight approved medicines for different blood cancers. But adapting the powerful technique, which invol...

Read source

fiercebiotech.com /1 month ago

Has Novartis’ T-Charge been overtaken by in vivo CAR-Ts? Execs argue there’s room for both

It’s been more than four years since Novartis shook up the CAR-T space with its T-Charge platform. But that’s a lifetime in the fast-moving world of cell therapies.

Read source

fiercebiotech.com /2 weeks ago

Caris Life Sciences launches cancer blood test ‘Caris Detect’

Caris Life Sciences has launched a new oncology blood test designed alongside AI modelling to pick up cancer at earlier stages.

Read source

story.motherhood.com.my /3 weeks ago

Applecrumby and CARs International Launch Exclusive Giveaway “Fresh Rides, Happy Dads”Campaign

In celebration of Father’s Month, Applecrumby and CARs International are joining forces to reward families with practical everyday cleaning essentials and premium wipes and... The...

Read source

cleantechnica.com /1 month ago

In the US, Cars Need Visas Too

Imagine this scene: The line at the border stretched for miles. Cars idled nervously, their engines humming like anxious hearts. Above the checkpoint, a new sign gleamed in bureauc...

Read source

fiercebiotech.com /1 month ago

ASCO: Lilly exec points to ‘nutty’ 100% response rate for in vivo CAR-T as justifying Kelonia buyout

Kelonia Therapeutics has shared the largest slice of data yet for an in vivo CAR-T, helping to justify the $3.2 billion price tag that Eli Lilly recently paid to buy the Boston bio...

Read source

newswire.com /2 weeks ago

Priority Tire Joins Cosmo Tires to Take on Blood Cancer

Tire retailers set aside their rivalry for a greater cause. Priority Tire is proud to support Blood Cancer United with every set of Cosmo tires sold. Tire retailers set aside their...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.